- Folate deficiency anemia is also defined knowns as Vitamin B9 deficiency anemia. It occurs when shortage of vitamin B12 triggers the body to produce inadequate or when an abnormally large amount of red blood cells eventually distresses the body to be efficient. Folate plays a significant role in the synthesis of genetic material such as DNA, RNA and proteins.
- The demand for these microscopes is significantly driven by the increasing prevalence of related conditions and advancements in treatment protocols.
- North America is expected to dominate the Folate Deficiency Anemia Drugs market due to advanced healthcare infrastructure and increasing focus on managing anemia-related complications in surgeries
- Asia-Pacific is expected to be the fastest growing region in the Folate Deficiency Anemia Drug market during the forecast period due to by rising awareness of anemia’s impact on overall health
- Dietary Folate Deficiency Anemia segment is expected to dominate the market with a market share of 56.22% due to its high prevalence and demand for precise treatments, as well as the increasing need for optimized drug therapies for anemia-related health conditions
